Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Future Science OA|January 25, 2017
Looking to a future of improved diabetes management: interview with Professor Steve BainSteve BainCurrent Opinion in Genetics & Development|March 22, 2021
Copy number variation and neuropsychiatric illnessElliott Rees, George KirovExpert Opinion on Drug Safety|April 8, 2017
Cardiovascular safety of liraglutide for the treatment of type 2 diabetesR A Chudleigh, Steve BainGenome Medicine|May 1, 2020
Translating insights from neuropsychiatric genetics and genomics for precision psychiatryElliott Rees, Michael J OwenDiabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 9, 2013
Evaluation of insulin use and value for money in type 2 diabetes in the United kingdomJason Gordon, Marc Evans, Phil McEwan, et al.Schizophrenia Bulletin|March 28, 2012
De novo mutation in schizophreniaElliott Rees, George Kirov, Michael C O'Donovan, et al.Molecular Psychiatry|January 26, 2019
Schizophrenia-associated genomic copy number variants and subcortical brain volumes in the UK BiobankAnthony Warland, Kimberley M Kendall, Elliott Rees, et al.Biological Psychiatry|August 23, 2011
De novo rates and selection of schizophrenia-associated copy number variantsElliott Rees, Valentina Moskvina, Michael J Owen, et al.JMIR AI|September 18, 2025
Large Language Model-Supported Identification of Intellectual Disabilities in Clinical Free-Text Summaries: Mixed Methods StudyAleksandra Edwards, Antonio F Pardiñas, George Kirov, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 21, 2025
Real-World Comparisons Between Glucagon-Like Peptide-1 Receptor Agonists and Other Glucose-Lowering Agents in Type 2 Diabetes: Retrospective Analyses of Cardiovascular and Economic Outcomes in EnglandDerek Connolly, Edward Collins, Hongye Ren, et al.Pageof 9